thymopentin has been researched along with Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Han, Z; Li, J; Li, P; Wang, F; Xiao, Y; Zhang, Q; Zhang, X; Zheng, L | 1 |
| Awaya, A; Hayashi, T; Onodera, T; Sato, M; Shimizu, S; Taniguchi, T; Tsuda, T; Yoshihara, K | 1 |
2 other study(ies) available for thymopentin and Atrophy
| Article | Year |
|---|---|
The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Atrophy; B7-2 Antigen; Cyclophosphamide; Drug Synergism; Histocompatibility Antigens Class I; Hydrocortisone; Immunologic Factors; Immunosuppressive Agents; Interferon-gamma; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Protein Binding; Skin Neoplasms; Surface Plasmon Resonance; Thymalfasin; Thymocytes; Thymopentin; Thymosin; Thymus Gland; Time Factors; Toll-Like Receptor 2; Tumor Burden | 2013 |
Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2.
Topics: Age Factors; Animals; Animals, Suckling; Antibody Formation; Atrophy; Autoantibodies; Female; Immune Tolerance; Immunotherapy, Adoptive; Male; Mice; Mice, Inbred BALB C; Reoviridae; Reoviridae Infections; Spleen; Thymic Factor, Circulating; Thymopentin; Thymus Gland | 1991 |